QRS interval widening appears to be highly specific for the diagnosis of hyperkalemia in patients with end-stage kidney disease. ECG changes, in general, have poor sensitivities for hyperkalemia in ...

The ECG findings of hyperkalemia change as the potassium level increases. From earliest to latest, the ECG findings include: Peaked T waves best seen in the precordial leads, shortened QT interval and ...

AliveCor has received approval from the Food and Drug Administration (FDA) to develop a non-invasive method of detecting high blood potassium levels. The startup, which chiefly focuses on monitoring ...

In patients with severe hyperkalemia, the Brugada syndrome ECG phenotype is associated with a high prevalence of malignant arrhythmias and all-cause mortality. Among patients with severe hyperkalemia ...

AccurKardia, an innovator in ECG-based diagnostics technology, today announced that AK+ Guard™ has been selected as winner of ...

AliveCor already offers the first FDA-approved EKG reader for Apple Watch with its Kardiaband system, and a new study shows how that hardware may be capable of even more medical achievements. A new ...

NEW YORK, September 16, 2025--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a multicenter clinical pilot of AK+ Guard TM, an FDA ...

Although KardiaBand is a band for Apple Watch, it has a sensor for measuring electrocardiogram in the band and it is possible to obtain ECG by simple operation,The US Food and Drug Administration (FDA ...

Please provide your email address to receive an email when new articles are posted on . Hyperkalemia is a common electrolyte disorder, especially among patients with chronic kidney disease (CKD), ...

Although serum potassium monitoring is recommended to reduce the risk of hyperkalemia, only a small percentage of patients taking RAAS inhibitors are monitored. Hyperkalemia diagnosis is often missed ...